• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glenmark Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20600.0
  • ISIN : INE935A01035
2,419.20 4 (0.17%)
  • As on 12 Sep 2026 (EOD)

  • Today’s Low

    2,384.10

  • Today’s High

    2,431.90

  • Open

    2,411.20

  • Perv Close

    2,415.00

  • 52W Low

    1,792.60

  • 52W High

    2,537.60

Key Indicators

  • P/E(TTM)

    46.72

  • Mar.Cap (₹Cr.)

    68,275.79

  • Div & Yield %

    0.21

  • Book Value(₹)

    855.71

  • Debt-Equity Ratio

    0.17

  • AGM Date

    11-Sep-2026

  • EPS

    51.73

  • P/E Ratio

    46.72

Financials Ratios

  • Debt-Equity Ratio

    0.34

  • Mar.Cap (₹Cr.)

    68,275.79

  • RONW (%)

    -50.87

  • ROCE (%)

    12.05

Score Board

  • Equity (₹ in Cr.)

    28.22

  • BV (₹)

    855.70

  • Sales( ₹ in Cr.)

    8,440.10

  • NP (in Cr.)

    942.47

  • NP Var(%)

    -47.0

  • Div%

    500.0

  • CPS (₹)

    41.80

  • EPS (₹)

    33.40

  • Traded Value (₹ in Lakhs)

    68,210.88

  • 52 Week High

    2,537.60

  • 52 Week Low

    1,792.60

  • Price BSE

    2417.0

  • Price NSE

    2,419.00

  • Market Capital( in Cr.)

    68,210.88

  • P/C Ratio

    57.90

  • P/E Ratio

    72.40

  • Price Vs.BV

    33.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 8,440.10 9,226.41 7,891.12 8,220.66 8,141.58 7,567.93
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 8,440.10 9,226.41 7,891.12 8,220.66 8,141.58 7,567.93
Other Income 772.02 356.37 6,238.36 985.94 1,044.96 470.13
Stock Adjustments 105.42 -44.48 103.07 31.37 16.13 -5.24
Total Income 9,317.54 9,538.30 14,232.55 9,237.97 9,202.67 8,032.82
EXPENDITURE :            
Raw Materials 3,184.37 3,154.65 3,313.19 3,427.07 3,425.06 2,944.53
Power and Fuel Cost 112.65 114.62 104.92 95.09 91.34 80.49
Employee Cost 1,790.41 1,603.50 1,434.78 1,346.51 1,193.20 1,107.40
Other Manufacturing Expenses 370.83 372.36 375.32 304.66 347.04 267.26
Selling and Administration Expenses 1,593.61 1,305.30 1,199.17 1,246.10 1,062.89 914.37
Miscellaneous Expenses 2,217.11 566.49 325.15 855.71 349.97 358.30
Employee Benefit Expenses 1,790.41 1,603.50 1,434.78 1,346.51 1,193.20 1,107.40
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 9,268.97 7,116.92 6,752.52 7,275.13 6,469.50 5,672.35
Operating Profit 48.57 2,421.38 7,480.02 1,962.84 2,733.18 2,360.47
Interest 78.75 48.73 277.11 206.82 236.04 265.90
Gross Profit -30.18 2,372.65 7,202.91 1,756.02 2,497.14 2,094.57
Depreciation 235.89 218.63 202.16 184.15 159.70 150.82
Profit Before Tax -266.07 2,154.02 7,000.75 1,571.87 2,337.44 1,943.75
Current Tax -724.52 600.76 1,049.99 386.93 411.08 343.62
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 659.25 -57.09 783.46 -23.83 -71.42 -49.31
Reported Net Profit -200.80 1,610.35 5,167.29 1,208.77 1,997.79 1,649.45
Extraordinary Items -1,143.27 -152.91 3,742.26 -369.56 354.02 59.87
Adjusted Net Profit 942.47 1,763.26 1,425.03 1,578.33 1,643.77 1,589.58
Adjustment below Net Profit -16.96 -6.47 -4.76 0.63 1.61 2.48
P & L Balance brought forward 22,581.15 21,088.13 16,002.82 14,863.96 12,921.86 11,340.47
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 266.25 110.87 77.22 70.54 57.30 70.54
P & L Balance carried down 22,097.15 22,581.15 21,088.13 16,002.82 14,863.96 12,921.86
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 500.00 250.00 250.00 250.00 250.00 250.00
Dividend Per Share(Rs) 5.00 2.50 2.50 2.50 2.50 2.50
Earnings Per Share-Unit Curr -7.12 57.07 183.11 42.84 70.80 58.46
Earnings Per Share(Adj)-Unit Curr -7.12 57.07 183.11 42.84 70.80 58.46
Book Value 855.79 868.35 814.01 633.57 593.21 524.84
Book Value(Adj)-Unit Curr 855.79 868.35 814.01 633.57 593.21 524.84

Shareholding Pattern

  • Promoter Group

    46.65%

  • Public Share Holding

    53.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,415,386 1.21 3,415,386 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 128,241,936 45.44 128,241,936 1
Others 0 0.00 0 0
Sub Total 131,657,322 46.65 131,657,322 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 107,037 0.04 107,037 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 290,043 0.10 290,043 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 58,959,712 20.89 58,959,712 376
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,866,650 1.02 2,866,650 18
Mutual Funds / UTI 47,294,735 16.76 47,294,735 37
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,050,205 0.73 2,050,205 36
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 111,568,382 39.54 111,568,382 473
2] Non Institution
Bodies Corporate 5,857,675 2.08 5,857,675 1,330
Clearing Members 637 0.00 637 5
Directors of their Relatives 35 0.00 35 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,319,787 0.82 2,315,787 6,325
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 541,779 0.19 541,779 3,551
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,595,046 2.69 6,995,046 14
Individuals holding nominal share capital up to Rs. 1 lakh 22,308,732 7.91 22,101,398 199,701
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 64,236 0.02 64,236 9
Others 287,178 0.10 287,178 3
Sub Total 38,975,105 13.81 38,163,771 210,939
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 282,200,809 100.00 281,389,475 211,418

Company Background

Glenmark Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Glenmark Pharmaceuticals Ltd
  • BSE Code : 20600.0
  • ISIN : INE935A01035

  • Incorporation Year

    1977

  • Registered Office

    B/2 Mahalaxmi Chambers
    22 Bhulabhai Desai Road, Mumbai,
    Maharashtra-400026

  • Telephone

    91-22-40189999

  • FAX

    91-22-40189986

  • Chairman

    Glenn Saldanha

  • Managing Director

    Glenn Saldanha

  • Company Secretary

    Rashmi Khandelwal.

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glenmark Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glenmark Pharma. 2,416.90 9,212.12 8,440.10 333.37 6.30
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77